Janux Therapeutics, Inc.
Returns on Capital
| Period | ROE | ROI | ROA |
|---|---|---|---|
| Jun 2020 | 20.8% | 20.8% | — |
| Sep 2020 | 9.6% | 9.6% | — |
| Mar 2021 | 13.6% | 13.6% | — |
| Jun 2021 | -1.6% | -1.6% | -1.6% |
| Sep 2021 | -2.9% | -2.9% | -2.8% |
| Dec 2021 | -3.7% | -3.7% | -3.5% |
| Mar 2022 | -3.8% | -3.8% | -3.6% |
| Jun 2022 | -4.9% | -4.9% | -4.4% |
| Sep 2022 | -5.0% | -5.0% | -4.4% |
| Dec 2022 | -5.0% | -5.0% | -4.4% |
| Mar 2023 | -5.6% | -5.6% | -4.9% |
| Jun 2023 | -5.8% | -5.8% | -5.1% |
| Sep 2023 | -3.3% | -3.3% | -3.0% |
| Dec 2023 | -3.4% | -3.4% | -3.1% |
| Mar 2024 | -2.3% | -2.3% | -2.1% |
| Jun 2024 | -0.9% | -0.9% | -0.9% |
| Sep 2024 | -4.3% | -4.3% | -4.0% |
| Dec 2024 | -2.0% | -2.0% | -1.9% |
| Mar 2025 | -2.3% | -2.3% | -2.2% |
| Jun 2025 | -3.4% | -3.4% | -3.3% |
| Sep 2025 | -2.5% | -2.5% | -2.4% |
| Dec 2025 | -3.3% | -3.3% | -3.2% |
| Mar 2026 | -2.6% | -2.6% | -2.4% |
| Jun 2026 | -2.4% | -2.4% | -2.2% |